Next Generation Blood Gas Monitors Systems Market

By Product;

Portable and Bench-Top

By End-User;

Hospitals, Clinical Laboratories, Cardiac Centers and Others

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn685751121 Published Date: September, 2025 Updated Date: October, 2025

Next Generation Blood Gas Monitors System Market Overview

Next Generation Blood Gas Monitors System Market (USD Million)

Next Generation Blood Gas Monitors System Market was valued at USD 745.39 million in the year 2024. The size of this market is expected to increase to USD 1362.59 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 9.0%.


Next Generation Blood Gas Monitors Systems Market

*Market size in USD million

CAGR 9.0 %


Study Period2025 - 2031
Base Year2024
CAGR (%)9.0 %
Market Size (2024)USD 745.39 Million
Market Size (2031)USD 1362.59 Million
Market ConcentrationMedium
Report Pages343
745.39
2024
1362.59
2031

Major Players

  • Siemens Healthineers
  • Abbott Laboratories
  • Radiometer Medical
  • Instrumentation Laboratory
  • Nova Biomedical

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Next Generation Blood Gas Monitors Systems Market

Fragmented - Highly competitive market without dominant players


The Next Generation Blood Gas Monitors Systems Market is witnessing significant growth as hospitals and clinics adopt real-time, accurate, and efficient diagnostic solutions. With around 45% of patient-critical decisions depending on blood gas measurements, advanced monitoring systems are becoming indispensable. Their ability to provide rapid results, compact designs, and seamless digital integration makes them vital for modern healthcare.

Technological Advancements
Advances in wireless monitoring, miniaturized sensors, and AI-driven analysis are fueling adoption. Close to 50% of next-gen devices now feature these innovations, allowing remote access, continuous monitoring, and higher diagnostic accuracy. These improvements empower clinicians with reliable insights for better patient outcomes.

Accuracy and Efficiency
New-generation monitors deliver up to 35% greater accuracy compared to conventional systems. Enhanced automation, simplified interfaces, and faster turnaround times are minimizing diagnostic delays and errors, strengthening their use in critical care.

Expanding Applications
Adoption is growing across emergency care, ICUs, and surgical environments, where over 60% of hospitals now rely on advanced systems. Their application in respiratory monitoring, neonatal care, and perioperative management highlights their versatility in supporting diverse clinical needs.

Future Outlook
More than 55% of diagnostic platforms will incorporate these next-gen solutions. With features such as AI-based predictive analytics, connected health systems, and real-time data sharing, blood gas monitors will continue to enhance patient care and define the future of medical diagnostics.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product
    2. Market Snapshot, By End-User
    3. Market Snapshot, By Region
  4. Next Generation Blood Gas Monitors System Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Technological advancements
        2. Increasing chronic diseases
        3. Growing aging population
        4. Rising healthcare expenditure
        5. Enhanced diagnostic accuracy
      2. Restraints
        1. High equipment costs
        2. Limited healthcare infrastructure
        3. Stringent regulatory requirements
        4. Skilled personnel shortage
        5. Economic instability concerns
      3. Opportunities
        1. Emerging market expansion
        2. Telemedicine integration possibilities
        3. Advancements in AI
        4. Point-of-care innovations
        5. Personalized medicine growth
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Next Generation Blood Gas Monitors Systems Market, By Product, 2021 - 2031 (USD Million)
      1. Portable
      2. Bench-Top
    2. Next Generation Blood Gas Monitors Systems Market, By End-User, 2021 - 2031 (USD Million)
      1. Hospitals
      2. Clinical Laboratories
      3. Cardiac Centers
      4. Others
    3. Next Generation Blood Gas Monitors System Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profile
      1. Bayer
      2. Convergent Technologies
      3. Alere, Inc.
      4. Roche Diagnostics
      5. Samsung Medison
      6. Nova Stat
      7. Medica
      8. Radiometer Medical
      9. Abbott Point of Care
      10. Nova Biomedical
      11. Siemens Healthcare
      12. Erba
      13. Edan Instruments
      14. Dalko Diagnostics
  7. Analyst Views
  8. Future Outlook of the Market